Literature DB >> 1932932

Parkinson's disease as community health problem: study in Norwegian nursing homes. The Norwegian Study Group of Parkinson's Disease in the Elderly.

J P Larsen1.   

Abstract

OBJECTIVE: To examine the extent of under-diagnosis and overdiagnosis of Parkinson's disease and to determine quality of treatment in a defined population.
DESIGN: Clinical evaluation of an elderly population.
SETTING: 40 Norwegian nursing homes.
SUBJECTS: 3322 residents of nursing homes, of whom 500 were selected by nursing staff for evaluation on the basis of a structured information programme on Parkinson's disease and 269 were examined in detail by neurologists. MAIN OUTCOME MEASURES: Patients' scores on clinical rating scales, diagnosis of parkinsonism, and effect of changing drug treatment.
RESULTS: 169 (5.1%) patients were found to have clinical idiopathic Parkinson's disease, 31 of whom had not had the disease diagnosed previously. In addition, 31 patients without the disease were taking antiparkinsonian drugs unnecessarily. Eighty patients were judged to be receiving "optimal" treatment. In the remaining 58, the treatment was changed, and 36 patients showed a definite functional improvement after a 12 week observation period.
CONCLUSIONS: The quality of life of many elderly patients with Parkinson's disease could be improved by increasing medical and neurological services.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932932      PMCID: PMC1671011          DOI: 10.1136/bmj.303.6805.741

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

Review 1.  Parkinson's disease.

Authors:  C D Marsden
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

2.  Parkinson's disease.

Authors:  N P Quinn; F A Husain
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

3.  [Nursing homes patients with Parkinson disease: treatment].

Authors:  J P Larsen; E G Nessler; R Strandjord
Journal:  Tidsskr Nor Laegeforen       Date:  1988-06-20

4.  [Nursing homes patients with Parkinson disease: diagnosis].

Authors:  J P Larsen; E G Nessler; R Strandjord
Journal:  Tidsskr Nor Laegeforen       Date:  1988-06-20

5.  Diagnostic problems in Parkinson's disease.

Authors:  A Barbeau
Journal:  Clin Neurol Neurosurg       Date:  1984       Impact factor: 1.876

6.  Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi.

Authors:  B S Schoenberg; D W Anderson; A F Haerer
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

7.  Epidemiology of Parkinson's disease in Finland.

Authors:  R J Marttila; U K Rinne
Journal:  Acta Neurol Scand       Date:  1976-02       Impact factor: 3.209

8.  Parkinson's disease in a Scottish city.

Authors:  W J Mutch; I Dingwall-Fordyce; A W Downie; J G Paterson; S K Roy
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

9.  Epidemiology of parkinsonism: incidence, classification, and mortality.

Authors:  A H Rajput; K P Offord; C M Beard; L T Kurland
Journal:  Ann Neurol       Date:  1984-09       Impact factor: 10.422

10.  A new rating scale for dementia syndromes.

Authors:  C G Gottfries; G Bråne; B Gullberg; G Steen
Journal:  Arch Gerontol Geriatr       Date:  1982-12       Impact factor: 3.250

  10 in total
  4 in total

Review 1.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 2.  Approach to diagnosis of Parkinson disease.

Authors:  Christopher Frank; Giovanna Pari; John P Rossiter
Journal:  Can Fam Physician       Date:  2006-07       Impact factor: 3.275

3.  Admission of Parkinsonian patients to a neurological ward in a community hospital.

Authors:  Colin Klein; Tatiana Prokhorov; Ala Miniovitz; Eugenia Dobronevsky; Jose Martin Rabey
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

4.  Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.

Authors:  Meredith A Achey; Christopher A Beck; Denise B Beran; Cynthia M Boyd; Peter N Schmidt; Allison W Willis; Sara S Riggare; Richard B Simone; Kevin M Biglan; E Ray Dorsey
Journal:  Trials       Date:  2014-11-27       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.